October 22, 2024
TOPLINE: Guselkumab administered every 8 weeks (Q8W) leads to durable improvement in disease activity along with improvements in both skin and joint symptoms over 2 years […]
October 22, 2024
TOPLINE: Treatment with ritlecitinib sustained hair regrowth through week 48 in patients with alopecia areata (AA), and up to one third of nonresponders at week 24 […]
October 22, 2024
TOPLINE: Higher doses of vitamin D3 supplementation did not significantly reduce cardiac biomarkers in older adults with low serum vitamin D levels. The STURDY trial found […]
October 21, 2024
TOPLINE: Individuals using contraceptive pills, patches, and rings must frequently interact with the healthcare system for continued use. More than half of US contraceptive users prefer […]
October 21, 2024
TOPLINE: In healthy young adults, a single 30-minute bout of outdoor aerobic exercise significantly reduces fasting and 1-hour glucose levels during an oral glucose tolerance test […]
October 21, 2024
TOPLINE: The Fracture Risk Assessment Tool (FRAX), with bone mineral density, predicts the risk for major osteoporotic fractures and hip fractures in patients with cancer, but […]
October 21, 2024
TOPLINE: In 2022, an estimated 4.22 million US adults had glaucoma and nearly 1.5 million of them experienced some vision loss as a result, with notable […]
October 21, 2024
TOPLINE: Adolescent girls with polycystic ovary syndrome (PCOS) have an increased risk for hypertension, according to a new study which underscores the importance of blood pressure […]
October 21, 2024
TOPLINE: Better pre-diagnosis dietary quality is linked to improved survival in Black women with high-grade serous ovarian cancer (HGSOC). No significant survival association was found among […]